Search Within

Rachel Elizabeth Fanaroff

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (3)
  2. Review (1)
Groups
  1. Department of Medicine (4)
  2. Department of Pathology and Laboratory Medicine (4)
  3. GSK Faculty (4)
  4. Human Oncology and Pathogenesis Program (4)
  5. Solid Tumor Oncology Division (4)
  6. Thoracic Oncology (4)

More Groups

People
  1. Marc Ladanyi (4)
  2. Jason Chang (3)
  3. Jennifer Sauter (3)
  4. Marjorie Zauderer (3)
  5. Michael Offin (3)
  6. Soo Ryum Yang (3)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
Publications
  1. Annual Review of Pathology: Mechanisms of Disease (1)
  2. Clinical Cancer Research (1)
  3. Journal of Thoracic Oncology (1)
  4. Modern Pathology (1)
Publishers
  1. American Association for Cancer Research (1)
  2. Annual Reviews (1)
  3. Elsevier Inc. (1)
  4. Nature Research (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of histologic features with gene alterations in pleural mesothelioma
    Journal Article

    Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Diffuse pleural mesotheliomas with genomic near-haploidization: A newly recognized subset with distinct clinical, histologic, and molecular features
    Journal Article

    Yang, S. R.; Jayakumaran, G.; Benhamida, J.; Febres-Aldana, C. A.; Fanaroff, R.; Chang, J.; Gedvilaite, E.; Villafania, L. B.; Sauter, J. L.; Offin, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Diffuse pleural mesothelioma: Advances in molecular pathogenesis, diagnosis, and treatment
    Review

    Febres-Aldana, C. A.; Fanaroff, R.; Offin, M.; Zauderer, M. G.; Sauter, J. L.; Yang, S. R.; Ladanyi, M.
    Annual Review of Pathology: Mechanisms of Disease (2024)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save